The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Diagnosis and treatment of pyoderma gangrenosum
Open accessAbstract
Pyoderma gangrenosum is a rare but serious ulcerating skin disease, the treatment of which is mostly empirical.Pyoderma can present to a variety of health professionals and several variants exist that may not be recognised immediately.This can delay the diagnosis and have serious clinical consequences.1 The mainstay of treatment is long term immunosuppression, often with high doses of corticosteroids or low doses of ciclosporin.Recently, good outcomes have been reported for treatments based on anti-tumour necrosis factor , and infliximab proved effective in a randomised controlled trial.This article reviews the presentation of pyoderma gangrenosum and the therapeutic options available. MethodsWe used the keyword "pyoderma gangrenosum" to search Medline.We also searched the Cochrane database but found no Cochrane review on this disease. How can pyoderma be recognised?Several variants exist, but the most common one is classic pyoderma gangrenosum.This presents as a deep ulcer with a well defined border, which is usually violet or blue.The ulcer edge is often undermined (worn and damaged) and the surrounding skin is erythematous and indurated (fig 1).The ulcer often starts as a small papule or collection of papules, which break down to form small ulcers with a "cat's paw" appearance.These coalesce and the central area then undergoes necrosis to form a single ulcer.Classic pyoderma gangrenosum can occur on any skin surface, but is most commonly seen on the legs.Patients are often systemically unwell with symptoms such as fever, malaise, arthralgia, and myalgia.Lesions are usually painful and the pain can be severe.When the lesions heal the scars are often cribriform.Early diagnosis and prompt treatment reduce the risk of scars, and disfigurement may occur if the diagnosis is missed. 1 Pathergy occurs in 25-50% of cases-lesions develop at the site of minor trauma, so surgery or debridement are contraindicated.2
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Brooklyn, T. N., Dunnill, M. G. S., Shetty, A., Bowden, J. J., Williams, J. D. L., Griffiths, C. E. M., Forbes, A., Greenwood, R., & Probert, C. S. (2006) · Gut · doi:10.1136/gut.2005.074815 · Cited by 646
Self-citationReichrath, J., Bens, G., Bonowitz, A., & Tilgen, W. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.10.006 · Cited by 407
Bennett, M. L., Jackson, J. M., Jorizzo, J. L., Fleischer, A. B., White, W. L., & Callen, J. P. (2000) · Medicine · doi:10.1097/00005792-200001000-00004 · Cited by 404
Pyoderma gangrenosum: a report of 44 cases with follow-up
Driesch, P. V. D. (1997) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1997.20022083.x · Cited by 319
Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease
Regueiro, M. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00430-1 · Cited by 221
Superficial granulomatous pyoderma: A localized vegetative form of pyoderma gangrenosum
WILSON‐JONES, E., & WINKELMANN, R. K. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)70074-2 · Cited by 174
Pulse therapy. Therapeutic efficacy in the treatment of pyoderma gangrenosum
Johnson, R. B. (1982) · Archives of Dermatology · doi:10.1001/archderm.118.2.76 · Cited by 117
Berth‐Jones, J., Tan, S. V., GRAHAM-BROWN, R. A. C., & Pembroke, A. C. (1989) · Journal of Dermatological Treatment · doi:10.3109/09546638909086683 · Cited by 33
Cited by
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
Extraintestinal Manifestations of Inflammatory Bowel Disease
Vavricka, S. R., Schoepfer, A., Scharl, M., Lakatos, P. L., Navarini, A., & Rogler, G. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000392 · Cited by 909
Van Assche, G., Dignass, A., Reinisch, W., van der Woude, C. J., Sturm, A., De Vos, M., Guslandi, M., Oldenburg, B., Dotan, I., Marteau, P., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.09.009 · Cited by 894
Stange, E. F., Travis, S. P. L., Vermeire, S., Reinisch, W., Geboes, K., Barakauskiene, A., Feakins, R., Fléjou, J. F., Herfarth, H., Hommes, D. W., et al. (2008) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2007.11.001 · Cited by 555
Van Assche, G., Dignass, A., Bokemeyer, B., Danese, S., Gionchetti, P., Moser, G., Beaugerie, L., Gomollón, F., Häuser, W., Herrlinger, K., et al. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.005 · Cited by 463
Metadata
- Authors
- Brooklyn, T., Dunnill, G., & Probert, C.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2006-07-20
- Volume
- 333
- Issue
- 7560
- Pages
- 181-184
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2163929328
- Cited by
- 275
- References
- 9
- FWCI
- 7.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnosis and treatment of pyoderma gangrenosum. https://app.cochat.ai/papers/10.1136/bmj.333.7560.181
- The paper
- Brooklyn, T., Dunnill, G., & Probert, C. (2006). Diagnosis and treatment of pyoderma gangrenosum. BMJ. https://doi.org/10.1136/bmj.333.7560.181
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.